High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration-Reference-Cited by-同舟云学术

High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration

Published:2006-02-23 Issue:5 Volume:20 Page:840-846
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Paulsson K,Heidenblad M,Strömbeck B,Staaf J,Jönsson G,Borg Å,Fioretos T,Johansson B

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404145.pdf

Reference33 articles.

1. Mitelman F, Johansson B, Mertens F . Mitelman database of chromosome aberrations in cancer. 2005. http://cgap.nci.nih.gov/Chromosomes/Mitelman .

2. Paulsson K, Säll T, Fioretos T, Mitelman F, Johansson B . The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology. Cancer Genet Cytogenet 2001; 130: 160–165.

3. Albin M, Björk J, Welinder H, Tinnerberg H, Mauritzson N, Johansson B et al. Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents. Scand J Work Environ Health 2000; 26: 482–491.

4. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998; 92: 2322–2333.

5. Wolman SR, Gundacker H, Appelbaum FR, Slovak ML . Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a southwest oncology group study. Blood 2002; 100: 29–35.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare Ring Chromosome [r(15)]: Cytogenetic Abnormality in TP53-Mutated De Novo AML-M4 Masked as Gastrointestinal Bleed With Rapidly Progressing Hyperleukocytosis and Leukostasis;Cureus;2023-09-28

2. Genomic Applications in Hematologic Oncology;Genomic Applications in Pathology;2018-12-11

3. Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group;Cancer Genetics;2018-12

4. Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms;Cancer Genetics;2018-12

5. Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome;Modern Pathology;2017-12-15